Rainer J. Boehm

Insider Reports History

Identity
Location
Brisbane, CA
SEC record
Reporting signature
/s/ Barbara Chan as Attorney-in-Fact for Rainer Boehm
SEC evidence
Transaction evidence
Report rows are grouped by the transaction date disclosed in the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Holdings reported by Rainer J. Boehm:

Form 4 holding Director

HUMANIGEN, INC

Security class
Stock Option (Right to Buy)
Shares / value
73,307
Estimated value
$332,081
Report date
27 Jul 2022
Price
$4.53
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Omega Therapeutics, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
25,000
Estimated value
Report date
20 Jun 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Rainer J. Boehm

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .